ArriVent BioPharma (AVBP) Shares Outstanding (2023 - 2026)
ArriVent BioPharma (AVBP) posted Shares Outstanding (Entity) of $45.3 million for Q1 2026, up 6.73% sequentially from $42.5 million in Q4 2025, and up 33.1% YoY from $34.0 million in Q1 2025.
ArriVent BioPharma (AVBP) Shares Outstanding (2023 - 2026) Analysis & Trends
ArriVent BioPharma has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $45.3 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 33.1% year-over-year to $45.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.3 million (up 33.1% YoY) and the FY2025 annual result came in at $42.5 million, up 25.95% from the prior year.
- Shares Outstanding (Entity) improved to $45.3 million in Q1 2026 per AVBP's latest filing, from $42.5 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $45.3 million in Q1 2026 and troughed at $1.3 million in Q1 2023.
- A 4-year average of $25.7 million and a median of $33.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) soared 1845.25% in 2024, then climbed 11.88% in 2025.
- Over 4 years, Shares Outstanding (Entity) stood at $2.1 million in 2023, then soared by 1474.38% to $33.7 million in 2024, then rose by 25.95% to $42.5 million in 2025, then grew by 6.73% to $45.3 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $45.3 million, $42.5 million, and $40.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | ArriVent BioPharma | 1.43 Bn | 1.43 Bn | - | 47.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.07 Mn |
| Mar 31, 2026 | 45.07 Mn |
| Dec 31, 2025 | 38.46 Mn |
| Sep 30, 2025 | 41.91 Mn |
| Jun 30, 2025 | 35.01 Mn |
| Mar 31, 2025 | 33.90 Mn |
| Dec 31, 2024 | 31.47 Mn |
| Sep 30, 2024 | 33.58 Mn |
| Jun 30, 2024 | 33.50 Mn |
| Mar 31, 2024 | 25.05 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.29 Mn |